Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading healthcare conglomerate in China, has announced that its subsidiary, Fosun Diagnostics (Shanghai) Co., Ltd, has entered into a strategic partnership with Jointown Medical Devices Group Co., Ltd. The collaboration aims to enhance product commercialization and strengthen the supply chain ecosystem through resource exchange and leveraging complementary advantages. Financial details of the agreement were not disclosed.
Under this partnership, Fosun Diagnostics will benefit from Fosun Pharmaceutical’s extensive end-client coverage in public hospitals, complementing Jointown’s private medical institution channel platform. This mutual empowerment will expand Fosun Diagnostics’ commercial reach and service capabilities in third-party laboratories, physical examination centers, and private hospitals.- Flcube.com
